NDI Healthcare Fund Joins $5M Series A For SPR Therapeutics

Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. These funds will be used to commercialize pain therapies utilizing SPR’s proprietary peripheral nerve stimulation technology.

 

Read Full Article Here: http://www.pehub.com/180184/neurodevice-co-spr-therapeutics-raises-series-a/

Posted in and tagged with .

Why Open a Browser, get citybizlist in your InBox.